![](/img/cover-not-exists.png)
Double-blind, placebo-controlled first in human study to investigate an oral vaccine aimed to elicit an immune reaction against the VEGF-Receptor 2 in patients with stage IV and locally advanced pancreatic cancer
Andreas G Niethammer, Heinz Lubenau, Gerd Mikus, Philipp Knebel, Nicolas Hohmann, Christine Leowardi, Philipp Beckhove, Mustafa Akhisaroglu, Yingzi Ge, Marco Springer, Lars Grenacher, Markus W BuchlerVolume:
12
Language:
english
DOI:
10.1186/1471-2407-12-361
Date:
December, 2012
File:
PDF, 589 KB
english, 2012